Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Anti-donor MHC Class II Alloantibody Induces Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia.

Gorbacheva V, Fan R, Beavers A, Fairchild RL, Baldwin WM 3rd, Valujskikh A.

J Am Soc Nephrol. 2019 Oct 9. pii: ASN.2018111169. doi: 10.1681/ASN.2018111169. [Epub ahead of print]

PMID:
31597715
2.

Measuring alloreactive B cell responses in transplant recipients.

Hasgur S, Valujskikh A.

Curr Transplant Rep. 2019 Mar;6(1):99-105. Epub 2019 Jan 24.

PMID:
31588407
3.

Aquaporin 4 inhibition alters chemokine receptor expression and T cell trafficking.

Nicosia M, Miyairi S, Beavers A, Farr GW, McGuirk PR, Pelletier MF, Valujskikh A.

Sci Rep. 2019 May 15;9(1):7417. doi: 10.1038/s41598-019-43884-2.

4.

Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunity.

Tchekneva EE, Goruganthu MUL, Uzhachenko RV, Thomas PL, Antonucci A, Chekneva I, Koenig M, Piao L, Akhter A, de Aquino MTP, Ranganathan P, Long N, Magliery T, Valujskikh A, Evans JV, Arasada RR, Massion PP, Carbone DP, Shanker A, Dikov MM.

J Immunother Cancer. 2019 May 7;7(1):124. doi: 10.1186/s40425-019-0592-2.

5.

Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation.

Ayasoufi K, Zwick DB, Fan R, Hasgur S, Nicosia M, Gorbacheva V, Keslar KS, Min B, Fairchild RL, Valujskikh A.

JCI Insight. 2019 Apr 4;4(7). pii: 125489. doi: 10.1172/jci.insight.125489. eCollection 2019 Apr 4.

6.

Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity.

Tchekneva EE, Goruganthu MUL, Uzhachenko RV, Thomas PL, Antonucci A, Chekneva I, Koenig M, Piao L, Akhter A, de Aquino MTP, Ranganathan P, Long N, Magliery T, Valujskikh A, Evans JV, Arasada RR, Massion PP, Carbone DP, Shanker A, Dikov MM.

J Immunother Cancer. 2019 Apr 2;7(1):95. doi: 10.1186/s40425-019-0566-4. Erratum in: J Immunother Cancer. 2019 May 7;7(1):124.

7.

The neonatal Fc receptor: Key to homeostasic control of IgG and IgG-related biopharmaceuticals.

Baldwin WM 3rd, Valujskikh A, Fairchild RL.

Am J Transplant. 2019 Jul;19(7):1881-1887. doi: 10.1111/ajt.15366. Epub 2019 Apr 15. Review.

PMID:
30903736
8.

Runaway powerhouse: Donor mitochondria promote rejection.

Valujskikh A.

Am J Transplant. 2019 Jul;19(7):1875-1876. doi: 10.1111/ajt.15349. Epub 2019 Apr 2. No abstract available.

PMID:
30859714
9.

In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.

Yagisawa T, Tanaka T, Miyairi S, Tanabe K, Dvorina N, Yokoyama WM, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

Kidney Int. 2019 Feb;95(2):350-362. doi: 10.1016/j.kint.2018.08.041. Epub 2018 Nov 29.

PMID:
30503624
10.

Tracking Cell-cell Contacts: As Easy as Applying LIPSTIC.

Valujskikh A.

Transplantation. 2018 Aug;102(8):1198-1199. doi: 10.1097/TP.0000000000002264. No abstract available.

PMID:
30044361
11.

Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.

Tsuda H, Su CA, Tanaka T, Ayasoufi K, Min B, Valujskikh A, Fairchild RL.

JCI Insight. 2018 Feb 22;3(4). pii: 96940. doi: 10.1172/jci.insight.96940. eCollection 2018 Feb 22.

12.

Aquaporin 4 blockade improves survival of murine heart allografts subjected to prolonged cold ischemia.

Ayasoufi K, Kohei N, Nicosia M, Fan R, Farr GW, McGuirk PR, Pelletier MF, Fairchild RL, Valujskikh A.

Am J Transplant. 2018 May;18(5):1238-1246. doi: 10.1111/ajt.14624. Epub 2018 Jan 17.

13.

CD4+ T lymphocytes produce adiponectin in response to transplants.

Danturti S, Keslar KS, Steinhoff LR, Fan R, Dvorina N, Valujskikh A, Fairchild RL, Baldwin WM 3rd.

JCI Insight. 2017 Jun 15;2(12). pii: 89641. doi: 10.1172/jci.insight.89641. eCollection 2017 Jun 15.

14.

Depletion-Resistant CD4 T Cells Enhance Thymopoiesis During Lymphopenia.

Ayasoufi K, Fan R, Valujskikh A.

Am J Transplant. 2017 Aug;17(8):2008-2019. doi: 10.1111/ajt.14309. Epub 2017 May 17.

15.

Role of Memory T Cells in Allograft Rejection and Tolerance.

Benichou G, Gonzalez B, Marino J, Ayasoufi K, Valujskikh A.

Front Immunol. 2017 Feb 28;8:170. doi: 10.3389/fimmu.2017.00170. eCollection 2017. Review.

16.

Total Recall: Can We Reshape T Cell Memory by Lymphoablation?

Nicosia M, Valujskikh A.

Am J Transplant. 2017 Jul;17(7):1713-1718. doi: 10.1111/ajt.14144. Epub 2016 Dec 28. Review.

17.

Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.

Gorbacheva V, Fan R, Fairchild RL, Baldwin WM 3rd, Valujskikh A.

J Am Soc Nephrol. 2016 Nov;27(11):3299-3307. Epub 2016 Mar 28.

18.

Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.

Kohei N, Tanaka T, Tanabe K, Masumori N, Dvorina N, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

Kidney Int. 2016 Jun;89(6):1293-306. doi: 10.1016/j.kint.2016.02.030. Epub 2016 Apr 28.

19.

CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.

Ayasoufi K, Fan R, Fairchild RL, Valujskikh A.

J Immunol. 2016 Apr 1;196(7):3180-90. doi: 10.4049/jimmunol.1501435. Epub 2016 Feb 24.

20.

IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.

Iida S, Tsuda H, Tanaka T, Kish DD, Abe T, Su CA, Abe R, Tanabe K, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

J Immunol. 2016 Mar 15;196(6):2827-37. doi: 10.4049/jimmunol.1500876. Epub 2016 Feb 8.

21.

Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.

Baldwin WM 3rd, Valujskikh A, Fairchild RL.

Curr Opin Organ Transplant. 2016 Feb;21(1):7-14. doi: 10.1097/MOT.0000000000000262. Review.

22.

B cells regulate antidonor T-cell reactivity in transplantation.

Valujskikh AN.

Kidney Int. 2015 Sep;88(3):444-6. doi: 10.1038/ki.2015.171.

23.

Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model.

Abe T, Ishii D, Gorbacheva V, Kohei N, Tsuda H, Tanaka T, Dvorina N, Nonomura N, Takahara S, Valujskikh A, Baldwin WM 3rd, Fairchild RL.

Am J Transplant. 2015 May;15(5):1192-204. doi: 10.1111/ajt.13150. Epub 2015 Mar 2.

24.

Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants.

Kaul AM, Goparaju S, Dvorina N, Iida S, Keslar KS, de la Motte CA, Valujskikh A, Fairchild RL, Baldwin WM 3rd.

Am J Transplant. 2015 Feb;15(2):333-45. doi: 10.1111/ajt.13014. Epub 2015 Jan 12.

25.

IFN-γ production by memory helper T cells is required for CD40-independent alloantibody responses.

Gorbacheva V, Fan R, Wang X, Baldwin WM 3rd, Fairchild RL, Valujskikh A.

J Immunol. 2015 Feb 1;194(3):1347-56. doi: 10.4049/jimmunol.1401573. Epub 2014 Dec 29.

26.

B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.

Gorbacheva V, Ayasoufi K, Fan R, Baldwin WM 3rd, Valujskikh A.

Am J Transplant. 2015 Feb;15(2):346-57. doi: 10.1111/ajt.12984. Epub 2014 Dec 12.

27.

Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.

Ishii D, Rosenblum JM, Nozaki T, Schenk AD, Setoguchi K, Su CA, Gorbacheva V, Baldwin WM 3rd, Valujskikh A, Fairchild RL.

J Immunol. 2014 Oct 1;193(7):3816-24. doi: 10.4049/jimmunol.1303256. Epub 2014 Aug 29.

28.

CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity.

Rabant M, Gorbacheva V, Fan R, Yu H, Valujskikh A.

Am J Transplant. 2013 Nov;13(11):2831-2841. doi: 10.1111/ajt.12432. Epub 2013 Sep 18.

29.

Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection.

Iida S, Suzuki T, Tanabe K, Valujskikh A, Fairchild RL, Abe R.

Am J Transplant. 2013 Sep;13(9):2268-79. doi: 10.1111/ajt.12342. Epub 2013 Jul 8.

30.

Literature Watch: implications for transplantation.

Valujskikh A, Bromberg JS.

Am J Transplant. 2013 May;13(5):1117. doi: 10.1111/ajt.12278. No abstract available.

31.

The house that Jack built: expanding the concept of plasma cell niches.

Valujskikh A, Bromberg JS.

Am J Transplant. 2013 Mar;13(3):533. doi: 10.1111/ajt.12202. No abstract available.

32.

Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice.

Ayasoufi K, Yu H, Fan R, Wang X, Williams J, Valujskikh A.

Am J Transplant. 2013 Mar;13(3):589-99. doi: 10.1111/ajt.12068. Epub 2013 Jan 17.

33.

Unexpected role for MHC II-peptide complexes in shaping CD8 T-cell expansion and differentiation in vivo.

Do JS, Valujskikh A, Vignali DA, Fairchild RL, Min B.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12698-703. doi: 10.1073/pnas.1207219109. Epub 2012 Jul 16.

34.

The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients.

Sicard A, Phares TW, Yu H, Fan R, Baldwin WM 3rd, Fairchild RL, Valujskikh A.

Am J Transplant. 2012 Jul;12(7):1708-19. doi: 10.1111/j.1600-6143.2012.04009.x. Epub 2012 Mar 15.

35.

Memory T cells and their exhaustive differentiation in allograft tolerance and rejection.

Valujskikh A, Li XC.

Curr Opin Organ Transplant. 2012 Feb;17(1):15-9. doi: 10.1097/MOT.0b013e32834ee443. Review.

36.

B cells in cardiac transplants: from clinical questions to experimental models.

Baldwin WM 3rd, Halushka MK, Valujskikh A, Fairchild RL.

Semin Immunol. 2012 Apr;24(2):122-30. doi: 10.1016/j.smim.2011.08.017. Epub 2011 Sep 19. Review.

37.

Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker.

Cherkassky L, Lanning M, Lalli PN, Czerr J, Siegel H, Danziger-Isakov L, Srinivas T, Valujskikh A, Shoskes DA, Baldwin W, Fairchild RL, Poggio ED.

Am J Transplant. 2011 Jul;11(7):1388-96. doi: 10.1111/j.1600-6143.2011.03540.x. Epub 2011 May 12.

38.

Interleukin-17 promotes early allograft inflammation.

Gorbacheva V, Fan R, Li X, Valujskikh A.

Am J Pathol. 2010 Sep;177(3):1265-73. doi: 10.2353/ajpath.2010.091106. Epub 2010 Jul 22.

39.

Recent progress and new perspectives in studying T cell responses to allografts.

Valujskikh A, Baldwin WM 3rd, Fairchild RL.

Am J Transplant. 2010 May;10(5):1117-25. doi: 10.1111/j.1600-6143.2010.03087.x. Epub 2010 Mar 26. Review.

40.

Antibody-mediated rejection: emergence of animal models to answer clinical questions.

Baldwin WM 3rd, Valujskikh A, Fairchild RL.

Am J Transplant. 2010 May;10(5):1135-42. doi: 10.1111/j.1600-6143.2010.03065.x. Epub 2010 Mar 19. Review.

41.

Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts.

Schenk AD, Gorbacheva V, Rabant M, Fairchild RL, Valujskikh A.

Am J Transplant. 2009 Jan;9(1):64-73. doi: 10.1111/j.1600-6143.2008.02460.x. Epub 2008 Oct 31.

42.

Targeting T-cell memory: where do we stand?

Valujskikh A.

Curr Opin Organ Transplant. 2008 Aug;13(4):344-9. doi: 10.1097/MOT.0b013e3283061126. Review.

PMID:
18685328
43.

Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients.

Schenk AD, Nozaki T, Rabant M, Valujskikh A, Fairchild RL.

Am J Transplant. 2008 Aug;8(8):1652-61. doi: 10.1111/j.1600-6143.2008.02302.x. Epub 2008 Jun 18.

44.

ICOS-Dependent and -independent functions of memory CD4 T cells in allograft rejection.

Zhang QW, Rabant M, Schenk A, Valujskikh A.

Am J Transplant. 2008 Mar;8(3):497-506. doi: 10.1111/j.1600-6143.2007.02096.x.

45.

Memory T cells in allograft rejection.

Valujskikh A.

Adv Exp Med Biol. 2007;601:247-56. Review.

PMID:
17713012
46.

Frontiers in nephrology: T cell memory as a barrier to transplant tolerance.

Valujskikh A, Li XC.

J Am Soc Nephrol. 2007 Aug;18(8):2252-61. Epub 2007 Jul 18. Review. No abstract available.

47.

The challenge of inhibiting alloreactive T-cell memory.

Valujskikh A.

Am J Transplant. 2006 Apr;6(4):647-51. Review.

49.

Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival.

Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A.

J Immunol. 2006 Jan 15;176(2):770-7.

50.

Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway.

Bagai R, Valujskikh A, Canaday DH, Bailey E, Lalli PN, Harding CV, Heeger PS.

J Immunol. 2005 Jun 15;174(12):7711-5.

Supplemental Content

Loading ...
Support Center